ProfileGDS4459 / ENSG00000154767
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 72% 70% 77% 78% 77% 69% 75% 78% 73% 71% 65% 71% 78% 50% 79% 56% 69% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.3672
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.2170
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.9977
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.6878
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.8577
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.2469
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.7675
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.9978
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.6373
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.4571
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.9565
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.5371
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.9178
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.4250
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.1779
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.6156
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.1669